Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01573858Not ApplicableCompleted

Acupuncture and Clomiphene Citrate on Live Birth in Anovulatory Women With Polycystic Ovary Syndrome

Role: collaborator

NCT03506204Unknown

The Pelvic Floor Muscle Function in Chinese Primipara, a One-year Cohort Study

Role: collaborator

NCT03516266Unknown

A Cross-sectional Study of Female Pelvic Floor Muscle Function in Chinese Healthy Female

Role: collaborator

All 3 trials loaded